Paragraph 14

Summaries of reports and evaluations of any experimental and biological studies and of other preclinical, clinical or laboratory studies carried out with each medicinal product or its constituents, which in the view of the supplier are relevant to the assessment of the safety, quality or efficacy of the medicinal product, together with references to relevant publications or other clinical trials.